Answers are grounded in this paper and cite their sources.
the FDA approved aducanumab, the first new drug for Alzheimer's disease in almost 20 years-and notably, the first drug with a putative disease-modifying mechanism for the treatment of this devastating disorder, namely the removal of β-amyloid (or Aβ) plaques from the brain.
No takes yet. Share an insight, caveat, or question.
Lalli et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: